MI
Mirum Pharma
MIRM·NASDAQFoster City CAFounded 2018200 employees
Mid CapbiotechPublicHepatologyRare Disease
Platform: Livmarli PFIC
Market Cap
$2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (MIRM)
Loading MIRM stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zanuvorutinib | MIR-7624 | Phase 1/2 | 1 | IL-13 | NMOSDPsA | ||
| MIR-4070 | MIR-4070 | Phase 1/2 | 1 | USP1 | Huntington'sParkinson's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)